Literature DB >> 28928488

Ubiquitylation at the crossroads of development and disease.

Michael Rape1,2.   

Abstract

Human development requires intricate cell specification and communication pathways that allow an embryo to generate and appropriately connect more than 200 different cell types. Key to the successful completion of this differentiation programme is the quantitative and reversible regulation of core signalling networks, and post-translational modification with ubiquitin provides embryos with an essential tool to accomplish this task. Instigated by E3 ligases and reversed by deubiquitylases, ubiquitylation controls many processes that are fundamental for development, such as cell division, fate specification and migration. As aberrant function or regulation of ubiquitylation enzymes is at the roots of developmental disorders, cancer, and neurodegeneration, modulating the activity of ubiquitylation enzymes is likely to provide strategies for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28928488     DOI: 10.1038/nrm.2017.83

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  211 in total

1.  Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth.

Authors:  Anna Lasorella; Judith Stegmüller; Daniele Guardavaccaro; Guangchao Liu; Maria S Carro; Gerson Rothschild; Luis de la Torre-Ubieta; Michele Pagano; Azad Bonni; Antonio Iavarone
Journal:  Nature       Date:  2006-06-28       Impact factor: 49.962

Review 2.  Layers of DUB regulation.

Authors:  Danny D Sahtoe; Titia K Sixma
Journal:  Trends Biochem Sci       Date:  2015-06-11       Impact factor: 13.807

3.  Kinetic responses of β-catenin specify the sites of Wnt control.

Authors:  Ana R Hernández; Allon M Klein; Marc W Kirschner
Journal:  Science       Date:  2012-11-08       Impact factor: 47.728

Review 4.  The increasing complexity of the ubiquitin code.

Authors:  Richard Yau; Michael Rape
Journal:  Nat Cell Biol       Date:  2016-05-27       Impact factor: 28.824

5.  APC/C-mediated destruction of the centrosomal kinase Nek2A occurs in early mitosis and depends upon a cyclin A-type D-box.

Authors:  R S Hames; S L Wattam; H Yamano; R Bacchieri; A M Fry
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

6.  Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition.

Authors:  Jan Willem Voncken; Bernard A J Roelen; Mieke Roefs; Stijn de Vries; Els Verhoeven; Silvia Marino; Jacqueline Deschamps; Maarten van Lohuizen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-14       Impact factor: 11.205

7.  Deletion of DDB1 in mouse brain and lens leads to p53-dependent elimination of proliferating cells.

Authors:  Yong Cang; Jianxuan Zhang; Sally A Nicholas; Jayson Bastien; Baojie Li; Pengbo Zhou; Stephen P Goff
Journal:  Cell       Date:  2006-12-01       Impact factor: 41.582

8.  A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation.

Authors:  Ping Zhu; Wenlai Zhou; Jianxun Wang; Janusz Puc; Kenneth A Ohgi; Hediye Erdjument-Bromage; Paul Tempst; Christopher K Glass; Michael G Rosenfeld
Journal:  Mol Cell       Date:  2007-08-17       Impact factor: 17.970

9.  Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor.

Authors:  Colleen A McGourty; David Akopian; Carolyn Walsh; Amita Gorur; Achim Werner; Randy Schekman; Diana Bautista; Michael Rape
Journal:  Cell       Date:  2016-10-06       Impact factor: 41.582

10.  Structure and assembly pathway of the ribosome quality control complex.

Authors:  Sichen Shao; Alan Brown; Balaji Santhanam; Ramanujan S Hegde
Journal:  Mol Cell       Date:  2015-01-08       Impact factor: 17.970

View more
  139 in total

Review 1.  ITCH as a potential therapeutic target in human cancers.

Authors:  Qing Yin; Clayton J Wyatt; Tao Han; Keiran S M Smalley; Lixin Wan
Journal:  Semin Cancer Biol       Date:  2020-03-10       Impact factor: 15.707

Review 2.  Emerging role of FBXO22 in carcinogenesis.

Authors:  Jiangting Cheng; Min Lin; Man Chu; Longyuan Gong; Yanli Bi; Yongchao Zhao
Journal:  Cell Death Discov       Date:  2020-07-27

Review 3.  Visualizing ubiquitination in mammalian cells.

Authors:  Sjoerd Jl van Wijk; Simone Fulda; Ivan Dikic; Mike Heilemann
Journal:  EMBO Rep       Date:  2019-01-21       Impact factor: 8.807

Review 4.  N-degron and C-degron pathways of protein degradation.

Authors:  Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-08       Impact factor: 11.205

Review 5.  Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Blood Malignancies.

Authors:  Blanca T Gutierrez-Diaz; Wei Gu; Panagiotis Ntziachristos
Journal:  Trends Immunol       Date:  2020-03-02       Impact factor: 16.687

Review 6.  Cyclin D degradation by E3 ligases in cancer progression and treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  Semin Cancer Biol       Date:  2020-01-30       Impact factor: 15.707

7.  PI4Kγ2 Interacts with E3 Ligase MIEL1 to Regulate Auxin Metabolism and Root Development.

Authors:  Chun-Yan Zhao; Hong-Wei Xue
Journal:  Plant Physiol       Date:  2020-08-11       Impact factor: 8.340

Review 8.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

9.  Effect of SUMO-SIM Interaction on the ICP0-Mediated Degradation of PML Isoform II and Its Associated Proteins in Herpes Simplex Virus 1 Infection.

Authors:  Behdokht Jan Fada; Elie Kaadi; Subodh Kumar Samrat; Yi Zheng; Haidong Gu
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

10.  Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.

Authors:  Carl C Ward; Jordan I Kleinman; Scott M Brittain; Patrick S Lee; Clive Yik Sham Chung; Kenneth Kim; Yana Petri; Jason R Thomas; John A Tallarico; Jeffrey M McKenna; Markus Schirle; Daniel K Nomura
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.